Patent · US Active

Carba-nucleoside analogs for antiviral treatment

US8012942B2 · kind B2 · utility

93Cited by
2References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 9, 2010
Grant dateSep 6, 2011
Priority date
Expiry dateFeb 9, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are thieno[3,4-d]pyrimidin-7-yl and furo[3,4-d]pyrimidin-7-yl ribosides, riboside phosphates and prodrugs thereof as well as intermediates and methods of preparation. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.